期刊文献+

利用诱导性多能干细胞技术体外扩增造血干/祖细胞的初步研究

In vitro expansion hematopoietic/progenitor stem cells by directed differentiation of induced pluripotent stem cells
下载PDF
导出
摘要 目的 利用诱导性多能干细胞技术体外扩增造血干/祖细胞.方法 利用非整合型载体,将四个转录因子:Sox2、Klf4、Oct4和c-Myc导入脐血来源的造血干/祖细胞(CD34+细胞)重编程获得诱导性多能干细胞(iPSCs),再利用与小鼠骨髓基质细胞OP9共培养法将其定向分化成CD34+造血干/祖细胞.借助iPSCs可以在体外无限传代、大量扩增的特点,实现体外保存及大量扩增造血干/祖细胞的目的.结果 脐血CD34+细胞可以在体外重编程为非整合型iPSCs,并能够高效定向分化成为CD34+细胞,其分化效率比胚胎干细胞(ESCs)有显著提高.结论 利用诱导性多能干细胞技术体外大量扩增脐血造血干/祖细胞是一个可行的方案,具有良好的应用前景. Objective Expansion hematopoietic/progenitor stem cells by directed differentiation of induced pluripotent stem cells which induced from human cord blood hematopoietic stem cells.Methods Using episomal vectors of Sox2,Klf4,Oct4 and c-Myc to generate induced pluripotent stem cells from cord blood hematopoietic stem cells,we established integration-free iPSCs.And then we induced these cells differentiated into hematopoietic cells based on OP9 cells system in vitro.Result By examining CD34 positive cells,we found compared human ES cell line with cord blood sourced iPS cells could be differentiated into hematopoietic cells more efficiently.Conclusion A highly efficient method for expansion hematopoietic stem cells in vitro is successfully established,which is useable in clinical study.
出处 《国际医药卫生导报》 2015年第14期1995-2000,共6页 International Medicine and Health Guidance News
关键词 造血干/祖细胞 诱导性多能干细胞 造血分化 Hematopoietic/progenitor stem cells Induced pluripotent stem cells Hematopoietic differentiation
  • 相关文献

参考文献14

  • 1Chakraborty SK, Banu LA, Rahman MF, et al. Cord blood stem cells - a dream for future medicine[J].Mymensingh Med J, 2014, 23(3): 614-620.
  • 2Takahashi K. Tanabe K, Ohnuki M, el al. Induction of pluripotent stem cells from aduh human fibroblasts by defined factors[J].Cell, 2007, 131(5): 861-872.
  • 3Takayama N, Nishikii H, Usui J, et al. Generation of functional platelets from human emhryonic stem cells in vitro via ES-sacs, VEGF- promoted structures that concentrate hematnpoietic progenitors[J]. Blood 2008, 111(11): 5298-5306.
  • 4Woll PS, Grzywacz B, Tian X, et al. Human embryonic stem cells differentiate into a homogeneous population of natural killer cells with potent in vivu antitumnr activity[J].Blood. 200c), 113(24): 6094- 6101.
  • 5Timmermans F. Velghe 1, Vanwalleghem L, et el. Generation of T cells from human embryonic stem cell-derived hematopoietic zones[J].J Immunol, 2009, 182(11): 6879-6888.
  • 6Yokoyama Y. Suzuki T, Sakata-Yanagimoto M, et al. Derivation of functional mature neutrophils from human embryonic stem cells[J]. Bhmd, 2009, 113(26): 6584-6592.
  • 7Vodyanik MA, Thomson JA, Slukvin II. Leukosialin (CD43) defines hematopoietie progenitors in haman embryonic stem cell differentiatinn cultureslJl.Blnod, 2006, 108(6): 2095-2105.
  • 8Vodyanik MA, Bork JA, Thomson JA, et al. Human emblyonic stem cell-derived CD34+ cells: efficient production in lhe coculture with ()P9 s|rnmal cells anti analysis of lymphohematopoietic potential[J]. Blood, 2005. 105(2): 617-626.
  • 9Baehanova V, Verneris MR, DeFor T, et al. Prohmged survival in adults with acute lymphoblastic leukemia after reduced-intensity conditioning with cord blood or sibling donor transplantationlJ].Blood, 2009, 113(13): 2902-2905.
  • 10Wakitani S, Goto T, Pineda S J, et al. MesenchymaL cell-based repair of large, full-thickness defects of articular carlilage[J].J Bone Joint SurgAm, 1994, 76(4): 579-592.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部